American Society of Hematology

Subscribe to RSS

You must select a month AND year to filter.

• May 2012 Practice Update (part one)
• May 10, 2012
• May 2012 Practice Update (part one)

• NCATS Launches Collaborative Program with Industry and Researchers to Spur Therapeutic Development, Seeks Feedback
• May 8, 2012
• The National Institutes of Health (NIH) unveiled a collaborative program that will match researchers with a selection of pharmaceutical industry compounds to help scientists explore new treatments for patients.

• Implementation of Sunshine Act Delayed
• May 7, 2012
• Included in the Patient Protection and Affordable Care Act (PPACA) is a provision that will require drug and medical device companies to begin recording any physician payments that are worth more than $10 in 2012 and to report and make public on the Web.

• Rituximab Promotes Long-Term Response for Patients with Immune Destruction of Platelets
• May 7, 2012

• A new analysis concludes that rituximab, a drug commonly used to treat blood cancers, leads to treatment responses lasting at least five years in approximately one quarter of patients with low platelet counts and a risk of bleeding due to chronic immune thrombocytopenic purpura (ITP). In study results published online today in Blood, the Journal of the American Society of Hematology (ASH), investigators at Weill Cornell Medical College provide the very first long-term outcome data for patients with chronic ITP treated with rituxamab.

• Researchers Rejuvenate Blood-Forming Stem Cells in Mice (HealthDay News)
• May 7, 2012

• Researchers who found a way to rejuvenate aged blood-forming cells in mice say their achievement offers clues about how it may be possible to combat health problems associated with old age.

• ASH Comments to House Energy and Commerce Committee Re: Drug Shortage Provisions in PDUFA/MDUFMA
• May 3, 2012
• The American Society of Hematology (ASH) appreciates the opportunity to submit comments regarding the drug shortage provisions included in the House Committee on Energy and Commerce's draft Prescription Drug User Fee Act (PDUFA) and Medical Device User Fee and Modernization Act (MDUFMA) legislation.

• ASH Advocacy to Combat Drug Shortages Making a Difference; Language Included in Senate Appropriations Report
• May 3, 2012
• The Senate Appropriations Committee approved the FY 2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations bill on April 26.

• NIH Launches Collaborative Program with Industry and Researchers to Spur Therapeutic Development (NIH News)
• May 3, 2012

• The National Institutes of Health today unveiled a collaborative program that will match researchers with a selection of pharmaceutical industry compounds to help scientists explore new treatments for patients. NIH's new National Center for Advancing Translational Sciences (NCATS) has partnered initially with Pfizer, AstraZeneca, and Eli Lilly and Company which have agreed to make dozens of their compounds available for this initiative's pilot phase.

• Obama Administration Unveils Bioeconomy Blueprint, Calls for Acceleration of Non-Embryonic Stem Cell Research for Treatment of Blood Diseases
• May 1, 2012

• The White House released a “Bioeconomy Blueprint” last week outlining an approach to harness innovations and address national challenges in health, food, energy and the environment. The Blueprint is designed to guide work among federal agencies and with the private-sector to enhance economic growth, job creation, and innovation.

• April 2012 Practice Update (part two)
• April 26, 2012
• April 2012 Practice Update (part two)

• New Senate Drug Shortage Bill Focuses on Economic Incentives
• April 26, 2012
• Senator Orrin Hatch (R-UT), Ranking Member of the Senate Committee on Finance, released draft drug shortage legislation, ThePatient Access to Drugs in Shortage Act intended to provide economic incentives for drugs defined within the critical drug shortage parameters.

• ASH Advocacy to Combat Drug Shortages Influences Legislation in the U.S. Senate
• April 26, 2012
• ASH advocacy on drug shortages is making a difference as the Senate considers drug shortage legislation as part of their review of a larger bill known as the Prescription Drug User Fee Act (PDUFA).

• ASH Agenda for Hematology Research Identifies Most Promising Areas for Scientific Discovery
• April 24, 2012

• ASH today issued a report urging federal agencies to coordinate hematology research funding around seven specific high-need areas that would produce the greatest impact and translate into improvements in patient care in the United States.

• ASH Comments to Senate HELP Committee Re: Drug Shortage Provisions in PDUFA
• April 23, 2012
• The American Society of Hematology (ASH) is pleased to see that provisions to address drug shortages have been incorporated into the Senate Committee on Health, Education, Labor, and Pensions (HELP) draft Prescription Drug User Fee Act (PDUFA) legislation.

• ASH Committee on Government Affairs Visits Congress to Discuss Research Funding and Drug Shortages
• April 19, 2012
• Following its March 21 meeting in Washington, DC, the ASH Committee on Government Affairs visited more than 40 congressional offices to explain to Members of Congress and their staff the impact of potential cuts in funding to the National Institutes of Health (NIH) on research to find cures and treatments for patients with serious hematologic diseases.

< Prev Next > Page 1 of 148